Management of patients at high risk of developing skin melanoma: organizational and clinical aspects
https://doi.org/10.21518/2079-701X-2021-8-21-26
Abstract
Early diagnosis of skin melanoma is one of the most reliable ways to improve the prognosis for the life of patients with this tumor. Organization of medical care for patients with a high risk of developing melanoma, together with the use of non-invasive diagnostic methods and teaching the patient the principles of prevention and early diagnosis of skin malignancies should improve the survival rates of patients with melanoma. The article discusses the experience of implementing the Organizational model of medical care for patients with skin neoplasms in Moscow, as well as the key rules for managing patients at risk of developing skin melanoma with special emphasis on recommendations to patients for regular self-examination of the skin, lifestyle correction and the use of photoprotective agents.
About the Authors
A. V. Michenko
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology
Russian Federation
Russian Federation
17, Leninskiy Prospect, Moscow, 119071
O. V. Zhukova
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology; Peoples’ Friendship University of Russia
Russian Federation
Russian Federation
17, Leninskiy Prospect, Moscow, 119071
6, Miklukho-Maklay St., Moscow, 117198
M. N. Ostretsova
Peoples’ Friendship University of Russia
Russian Federation
Russian Federation
6, Miklukho-Maklay St., Moscow, 117198
O. L. Novozhilova
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology
Russian Federation
Russian Federation
17, Leninskiy Prospect, Moscow, 119071
References
1. Kaprin A.D., Starinskiy V.V., Petrova G.V. (eds.). Malignant neoplasms in Russia in 2018 (morbidity and mortality). Moscow: P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; 2019. 250 p. (In Russ.) Available at: https://oncology-association.ru/wpcontent/uploads/2020/09/2018.pdf.
2. Elwood J.M., Gallagher R.P., Worth A.J., Wood W.S., Pearson J.C. Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada Melanoma Study. J Natl Cancer Inst. 1987;78(1):37–44. doi: 10.1093/jnci/78.1.37.
3. Warner A.B., Postow M.A. Combination Controversies: Checkpoint Inhibition Alone or in Combination for the Treatment of Melanoma? Oncology (Williston Park). 2018;32(5):228–234. Available at: https://pubmed.ncbi.nlm.nih.gov/29847853.
4. Green A.C., Baade P., Coory M., Aitken J.F., Smithers M. Population-Based 20-Year Survival Among People Diagnosed With Thin Melanomas in Queensland, Australia. J Clin Oncol. 2012;30(13):1462–1467. doi: 10.1200/jco.2011.38.8561.
5. Potekaev N.N., Zhukova O.V., Novozhilova O.L., Mel’nichenko O.O., Kochetkov M.A., Michenko A.V. et al. Experience of the Moscow Center of Dermatovenerology and Cosmetology of the Moscow Department of Healt in the creation and implementation of the program ‘Early diagnosis and prevention of skin melanoma in Moscow’. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venereology. 2020;19(1): 53–63. (In Russ.) doi: 10.17116/klinderma20201901153.
6. Potekaev N.N., Michenko A.V., L’vov A.N., Zhukova O.V., Kochetkov M.A., Titov K.S. et al. Management tactics for patients with risk factors for malignant skin neoplasms in the practice of dermatologist. Moscow; 2018. (In Russ.) Available at: https://mosgorzdrav.ru/ru-RU/science/default/download/457.html.
7. Romajoscow: MIA; 2012. (In Russ.) Available at: https://elibrary.ru/item.asp?id=231216828.
8. Watts C.G., Dieng M., Morton R.L., Mann G.J., Menzies S.W., Cust A.E. Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma a systematic review. Br J Dermatol. 2015;172(1):33–47. doi: 10.1111/bjd.13403.
9. Potekaev N.N., Michenko A.V., Lvov A.N. Primary and secondary prevention of melanoma of the skin: an analytical review. Profilakticheskaya meditsina = Тhe Russian Journal of Preventive Medicine. 2018;21(5):136–143. (In Russ.) doi: 10.17116/profmed201821051136.
10. Rogers T., Marino M., Dusza S.W., Bajaj S., Marchetti M.A., Marghoob A. Triage amalgamated dermoscopic algorithm (TADA) for skin cancer screening. Dermatol Pract Concept. 2017;7(2):39–46. doi: 10.5826/dpc.0702a09.
11. Rosendahl C., Cameron A., McColl I., Wilkinson D. Dermatoscopy in routine practice: ‘chaos and clues’. Aust Fam Physician. 2012;41(7):482–487. Available at: https://pubmed.ncbi.nlm.nih.gov/22762066.
12. Soyer H.P., Argenziano G., Zalaudek I., Corona R., Sera F., Talamini R. et al. Three-point checklist of dermoscopy. A new screening method for early detection of melanoma. Dermatology. 2004;208(1):27–31. doi: 10.1159/000075042.
13. Psaty E.L., Scope A., Halpern A.C., Marghoob A.A. Defining the patient at high risk for melanoma. Int J Dermatol. 2010;49(4):362–376. doi: 10.1111/j.1365-4632.2010.04381.x.
14. Zhigulina A.G., Kliuchareva S.V., Novitskaia T.A. Cutaneous melanoma in a dermatologist’s practice. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venereology. 2013;11(3):113–117. (In Russ.) Available at: https://elibrary.ru/item.asp?id=20130877.
15. Grjng. Arch Dermatol. 1998;134(1):103–104. doi: 10.1001/archderm.134.1.103-a.
16. Akhmatova A.M., Potekaev N.N., Reshetov I.V., Tkachenko S.B., Michenko A.V., L’vov A.N. Early diagnostics of melanoma in dermatological practice. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venereology. 2012;10(2):32–36. (In Russ.) Available at: https://elibrary.ru/item.asp?id=18022343.
17. Marks R. Campaigning for melanoma prevention: a model for a health education program. J Eur Acad Dermatol Venereol. 2004;18(1):44–47. doi: 10.1111/j.1468-3083.2004.00802.x.
Review
For citations:
Michenko AV, Zhukova OV, Ostretsova MN, Novozhilova OL. Management of patients at high risk of developing skin melanoma: organizational and clinical aspects. Meditsinskiy sovet = Medical Council. 2021;(8):21-26. (In Russ.) https://doi.org/10.21518/2079-701X-2021-8-21-26
Views:
717
Email this article 